The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines
- Abstract
- The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) first was published in 2002, and has been revised four times, in 2006, 2012, 2017, and 2021. In this review, we compared recommendations from the recently revised KMAP-DD 2021 to four global clinical practice guidelines (CPGs) for depression published after 2010. The recommendations from the KMAP-DD 2021 were similar to those from other CPGs, although there were some differences. The KMAP-DD 2021 reflected social culture and the healthcare system in Korea and recent evidence about pharmacotherapy for depression, as did other recently published evidence-based guidelines. Despite some intrinsic limitations as an expert consensus-based guideline, the KMAP-DD 2021 can be helpful for Korean psychiatrists making decisions in clinical settings by complementing previously published evidence-based guidelines, especially for some clinical situations lacking evidence from rigorously designed clinical trials.
- All Author(s)
- Y. S. Woo
; W. M. Bahk
; J. S. Seo
; Y. M. Park
; W. Kim
; J. H. Jeong
; S. H. Shim
; J. G. Lee
; S. H. Jang
; C. M. Yang
; S. M. Wang
; M. H. Jung
; H. M. Sung
; I. H. Choo
; B. H. Yoon
; S. Y. Lee
; D. I. Jon
; K. J. Min
- Issued Date
- 2022
- Type
- Article
- Keyword
- Consensus; Depressive disorder; Guideline; Kmap-dd 2021; Pharmacotherapy
- Publisher
- 대한정신약물학회
- ISSN
- 1738-1088
; 2093-4327
- Citation Title
- Clinical Psychopharmacology and Neuroscience
- Citation Volume
- 20
- Citation Number
- 1
- Citation Start Page
- 37
- Citation End Page
- 50
- Language(ISO)
- eng
- DOI
- 10.9758/cpn.2022.20.1.37
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/1831
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.